However, the very similar associations between prolactin and breast cancer risk observed in our previous study of invasive disease [5] and the current study of in situ disease suggest that circulating prolactin may influence risk of invasive and in situ breast cancer via the same aetiological pathway. The gene discussed is PRL; the disease is breast cancer.